Flemming Steen Jensen net worth and biography

Flemming Jensen Biography and Net Worth

Insider of Ascendis Pharma A/S

Flemming Steen Jensen was named Executive Vice President, Product Supply and Quality at Ascendis Pharma after leading this function as Senior Vice President since 2015. Prior to Ascendis, Mr. Jensen served as Corporate Vice President for Global Pharma Consulting and Business Development and was a member of the management team at NNE Pharmaplan A/S, an engineering and consulting company (part of Novo Nordisk A/S), from October 2014 to July 2015. From 1999 to September 2014, Mr. Jensen served as Executive Vice President of Product Supply and was a member of the Board of Management of the pharmaceutical company ALK-Abelló A/S, Denmark. From 1986 to 1997, Mr. Jensen held several management positions relating to Development, Manufacturing and Engineering within Novo Nordisk A/S. Mr. Jensen is also a member of various Boards of Directors and Advisory Boards of privately held companies in the life sciences industry. Mr. Jensen holds a M.Sc. in Pharmacy from the University of Copenhagen.

How do I contact Flemming Steen Jensen?: The corporate mailing address for Jensen and other Ascendis Pharma A/S executives is TUBORG BOULEVARD 12, HELLERUP G7, DK-2900. Ascendis Pharma A/S can also be reached via phone at (457) 022-2244 and via email at [email protected]. Learn More on Flemming Steen Jensen's contact information.
Has Flemming Steen Jensen been buying or selling shares of Ascendis Pharma A/S?: During the last ninety days, Flemming Steen Jensen has sold $4,641,015.40 in shares of Ascendis Pharma A/S stock. Most recently, Flemming Steen Jensen sold 19,460 shares of the business's stock in a transaction on Monday, May 11th. The shares were sold at an average price of $238.49, for a transaction totalling $4,641,015.40. Learn More on Flemming Steen Jensen's trading history.
Are insiders buying or selling shares of Ascendis Pharma A/S?: In the last twelve months, insiders at the biotechnology company sold shares 1 times. They sold a total of 19,460 shares worth more than $4,641,015.40. The most recent insider tranaction occured on May, 11th when insider Flemming Steen Jensen sold 19,460 shares worth more than $4,641,015.40. Insiders at Ascendis Pharma A/S own 40.0% of the company. Learn More about insider trades at Ascendis Pharma A/S.
Information on this page was last updated on 5/11/2026.

Flemming Steen Jensen Insider Trading History at Ascendis Pharma A/S

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
5/11/2026	Sell	19,460	$238.49	$4,641,015.40

Flemming Steen Jensen Buying and Selling Activity at Ascendis Pharma A/S

Ascendis Pharma A/S Company Overview

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

Today's Range

Now: $242.90

$235.52

$245.69

50 Day Range

MA: $232.03

$215.54

$249.84

2 Week Range

Now: $242.90

$150.89

$250.74

Volume

272,480 shs

Average Volume

706,000 shs

Market Capitalization

$15.15 billion

P/E Ratio

28.02

Dividend Yield

N/A

Beta

0.41